Literature DB >> 15750044

Detection of lung cancer by sensor array analyses of exhaled breath.

Roberto F Machado1, Daniel Laskowski, Olivia Deffenderfer, Timothy Burch, Shuo Zheng, Peter J Mazzone, Tarek Mekhail, Constance Jennings, James K Stoller, Jacqueline Pyle, Jennifer Duncan, Raed A Dweik, Serpil C Erzurum.   

Abstract

RATIONALE: Electronic noses are successfully used in commercial applications, including detection and analysis of volatile organic compounds in the food industry.
OBJECTIVES: We hypothesized that the electronic nose could identify and discriminate between lung diseases, especially bronchogenic carcinoma.
METHODS: In a discovery and training phase, exhaled breath of 14 individuals with bronchogenic carcinoma and 45 healthy control subjects or control subjects without cancer was analyzed. Principal components and canonic discriminant analysis of the sensor data was used to determine whether exhaled gases could discriminate between cancer and noncancer. Discrimination between classes was performed using Mahalanobis distance. Support vector machine analysis was used to create and apply a cancer prediction model prospectively in a separate group of 76 individuals, 14 with and 62 without cancer. MAIN
RESULTS: Principal components and canonic discriminant analysis demonstrated discrimination between samples from patients with lung cancer and those from other groups. In the validation study, the electronic nose had 71.4% sensitivity and 91.9% specificity for detecting lung cancer; positive and negative predictive values were 66.6 and 93.4%, respectively. In this population with a lung cancer prevalence of 18%, positive and negative predictive values were 66.6 and 94.5%, respectively.
CONCLUSION: The exhaled breath of patients with lung cancer has distinct characteristics that can be identified with an electronic nose. The results provide feasibility to the concept of using the electronic nose for managing and detecting lung cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15750044      PMCID: PMC2718462          DOI: 10.1164/rccm.200409-1184OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  25 in total

1.  Support vector machine classification and validation of cancer tissue samples using microarray expression data.

Authors:  T S Furey; N Cristianini; N Duffy; D W Bednarski; M Schummer; D Haussler
Journal:  Bioinformatics       Date:  2000-10       Impact factor: 6.937

2.  Knowledge-based analysis of microarray gene expression data by using support vector machines.

Authors:  M P Brown; W N Grundy; D Lin; N Cristianini; C W Sugnet; T S Furey; M Ares; D Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Identification of upper respiratory bacterial pathogens with the electronic nose.

Authors:  Stephen Y Lai; Olivia F Deffenderfer; William Hanson; Marguerite P Phillips; Erica R Thaler
Journal:  Laryngoscope       Date:  2002-06       Impact factor: 3.325

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Differential expression of manganese superoxide dismutase and catalase in lung cancer.

Authors:  J Chung-man Ho; S Zheng; S A Comhair; C Farver; S C Erzurum
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

6.  An intelligent rapid odour recognition model in discrimination of Helicobacter pylori and other gastroesophageal isolates in vitro.

Authors:  A K Pavlou; N Magan; D Sharp; J Brown; H Barr; A P Turner
Journal:  Biosens Bioelectron       Date:  2000-10       Impact factor: 10.618

7.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

Authors:  M K Gould; C C Maclean; W G Kuschner; C E Rydzak; D K Owens
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

8.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.

Authors:  M Phillips; K Gleeson; J M Hughes; J Greenberg; R N Cataneo; L Baker; W P McVay
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

9.  Use of an electronic nose system for diagnoses of urinary tract infections.

Authors:  Alexandros K Pavlou; Naresh Magan; Cliodna McNulty; Jeff Jones; Dorothy Sharp; Jonathon Brown; Anthony P F Turner
Journal:  Biosens Bioelectron       Date:  2002-10       Impact factor: 10.618

10.  Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.

Authors:  Roberto F Machado; James K Stoller; Daniel Laskowski; Shuo Zheng; Joseph A Lupica; Raed A Dweik; Serpil C Erzurum
Journal:  J Appl Physiol (1985)       Date:  2002-08-30
View more
  98 in total

1.  Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.

Authors:  Peter J Mazzone; Xiao-Feng Wang; Yaomin Xu; Tarek Mekhail; Mary C Beukemann; Jie Na; Jonathan W Kemling; Kenneth S Suslick; Madhu Sasidhar
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

Review 2.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

3.  Proposed model for ONCHIT pre-case biosurveillance using multiple array sensing and non-invasive data capture.

Authors:  Richard Churchill; Daniel Lorence; Michael Richards
Journal:  J Med Syst       Date:  2009-04-24       Impact factor: 4.460

4.  Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis.

Authors:  Arend Kolk; Michael Hoelscher; Leonard Maboko; Jutta Jung; Sjoukje Kuijper; Michael Cauchi; Conrad Bessant; Stella van Beers; Ritaban Dutta; Tim Gibson; Klaus Reither
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

5.  Exhaled breath analysis: from occupational to respiratory medicine.

Authors:  Massimo Corradi; Antonio Mutti
Journal:  Acta Biomed       Date:  2005

6.  Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array.

Authors:  Peter J Mazzone; Jeffrey Hammel; Raed Dweik; Jie Na; Carmen Czich; Daniel Laskowski; Tarek Mekhail
Journal:  Thorax       Date:  2007-02-27       Impact factor: 9.139

7.  Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breath.

Authors:  A Mashir; K M Paschke; D van Duin; N K Shrestha; D Laskowski; M K Storer; B Yen-Lieberman; S M Gordon; M Aytekin; R A Dweik
Journal:  J Breath Res       Date:  2011-07-15       Impact factor: 3.262

Review 8.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

Review 9.  Applications of metabolomics to study cancer metabolism.

Authors:  Akash K Kaushik; Ralph J DeBerardinis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-25       Impact factor: 10.680

10.  Breath analysis in pulmonary arterial hypertension.

Authors:  Frank S Cikach; Adriano R Tonelli; Jarrod Barnes; Kelly Paschke; Jennie Newman; David Grove; Luma Dababneh; Sihe Wang; Raed A Dweik
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.